Over the last three months we have been developing business cases that explore four ideas from IP3. The aim was to investigate the potential market for the output of the projects should they go ahead, the resources required to deliver them, and to flesh out the specific outputs that the project would aim to deliver.
Controlled Substance Compliance Services (CSCS), a project managed by the Pistoia Alliance, which helps companies check the legal requirements around using controlled substances in pharmaceutical research, is set to expand to China.
The slides and recording of this webinar are now available. The webinar explored selected use cases and challenges for ontological engineering, an area considered to be critical for a successful life science sector.
The Pistoia Alliance’s new members include large global companies, startups, and academic organizations, including Amgen, Lundbeck, Dotmatics Limited, quattroresearch GmbH, Patcore Inc., Hewlett-Packard Company, the University of Reading, Cambridgene, and QFAB.
ChemAxon, a Pistoia Alliance member, has today released its new Biomolecule Toolkit product. The Biomolecule Toolkit includes HELM compatibility making it fully interoperable with an increasing number of other HELM-aware solutions and adopters.
The Pistoia Alliance Debates series will continue on Tuesday January 20th with a webinar entitled “Ontologies as the glue for knowledge management: use cases and challenges.”
An article describing CSCS, its Expert Community, and recent work to expand the project's scope to include Chinese legislation was published in Scrip Regulatory Affairs on January 9th.
The January 2015 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.
The presentation and recording from the Genomics, Pharmaceutical R&D & Healthcare: Are we there yet? Webinar held onThursday 11th December 2014 are available here.